Motor neuropathy with multifocal conduction block

G J Parry1

  • 1Department of Neurology, University of Minnesota School of Medicine, Minneapolis.

Seminars in Neurology
|September 1, 1993
PubMed

Insights

Multifocal motor neuropathy (MMN) may be a variant of chronic inflammatory demyelinating polyneuropathy (CIDP), not motor neuron disease (MND). Distinguishing MMN from CIDP and MND requires further research into glycolipid antibodies.

Area of Science:

  • Neurology
  • Clinical Electrophysiology
  • Immunology

Background:

  • Current understanding of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) is insufficient for clear differentiation.
  • The clinical and electrophysiologic similarities between MMN and Motor Neuron Disease (MND) are often overstated.
  • MMN is considered rare, but its prevalence may be underestimated given the existing case reports.

Purpose of the Study:

  • To re-evaluate the relationship between CIDP and MMN.
  • To clarify the distinction between MMN and MND.
  • To investigate the potential role of glycolipid antibodies in MMN and other motor syndromes.

Main Methods:

  • Clinical assessment of patients with suspected CIDP and MMN.
  • Electrophysiologic studies to differentiate between MMN, CIDP, and MND.
  • Review of existing literature on MMN, CIDP, and MND.

Main Results:

  • Evidence suggests MMN could be a multifocal, predominantly motor variant of CIDP.
  • MMN and MND are only superficially similar and can be distinguished using clinical and electrophysiologic criteria.
  • MMN may be more common than previously thought.

Conclusions:

  • MMN is likely a variant of CIDP, necessitating a revision of current diagnostic criteria.
  • MMN can be reliably differentiated from MND based on established clinical and electrophysiologic findings.
  • Further research is crucial to elucidate the precise relationship between CIDP and MMN and the significance of glycolipid antibodies.

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...